Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |